BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11672891)

  • 1. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.
    Gzyl A; Augustynowicz E; van Loo I; Slusarczyk J
    Vaccine; 2001 Nov; 20(3-4):299-303. PubMed ID: 11672891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
    Byrne S; Slack AT
    BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
    Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
    J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.
    Mastrantonio P; Spigaglia P; Oirschot HV; van der Heide HGJ; Heuvelman K; Stefanelli P; Mooi FR
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2069-2075. PubMed ID: 10463173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
    Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
    Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999.
    Cassiday P; Sanden G; Heuvelman K; Mooi F; Bisgard KM; Popovic T
    J Infect Dis; 2000 Nov; 182(5):1402-8. PubMed ID: 11023463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process].
    Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA
    Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.
    Mooi FR; van Oirschot H; Heuvelman K; van der Heide HG; Gaastra W; Willems RJ
    Infect Immun; 1998 Feb; 66(2):670-5. PubMed ID: 9453625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis.
    Fiett J; Letowska I; Gniadkowski M; Hryniewicz W
    J Microbiol Methods; 2003 Dec; 55(3):651-66. PubMed ID: 14607408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.
    Mooi FR; He Q; van Oirschot H; Mertsola J
    Infect Immun; 1999 Jun; 67(6):3133-4. PubMed ID: 10338531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in circulating Bordetella pertussis strains in Australia.
    Poynten M; McIntyre PB; Mooi FR; Heuvelman KJ; Gilbert GL
    Epidemiol Infect; 2004 Apr; 132(2):185-93. PubMed ID: 15061492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
    Fry NK; Neal S; Harrison TG; Miller E; Matthews R; George RC
    Infect Immun; 2001 Sep; 69(9):5520-8. PubMed ID: 11500425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic variability of Bordetella pertussis strains. Part I. Current knowledge].
    Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
    Przegl Epidemiol; 2003; 57(1):181-92. PubMed ID: 12926327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
    Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
    J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.
    Komatsu E; Yamaguchi F; Abe A; Weiss AA; Watanabe M
    Clin Vaccine Immunol; 2010 May; 17(5):807-12. PubMed ID: 20357056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants?
    He Q; Mäkinen J; Berbers G; Mooi FR; Viljanen MK; Arvilommi H; Mertsola J
    J Infect Dis; 2003 Apr; 187(8):1200-5. PubMed ID: 12695998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.